Successfully developing innovative drugs and enhancing research & development productivity
Pharmaceutical, biotech and medical device companies need to move new products into the market quickly to obtain sufficient benefit from a limited patent life and to compensate for development costs. Most major pharmaceutical manufacturers spend an average of 15 percent of sales on research & development. Given this substantial outlay and the long development cycle, companies have struggled to find ways to speed the introduction of new products into the marketplace.